Ekso Bionics Holdings – Consensus Indicates Potential 63.1% Upside

Broker Ratings

Ekso Bionics Holdings found using ticker (EKSO) have now 2 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 11 and 9 calculating the mean target price we have 10. Now with the previous closing price of 6.13 this now indicates there is a potential upside of 63.1%. The 50 day moving average now sits at 5.6 and the 200 day moving average is 5.54. The company has a market cap of $53m. You can visit the company’s website by visiting: http://www.eksobionics.com

Ekso Bionics Holdings designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. It primarily offers EksoNR, a bionic suit that provides the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke; and EksoUE, a wearable assistive device that helps to reduce the effect of gravity on the wearer’s shoulders and arms, as well as reduce fatigue while rehabilitation sessions to achieve a larger active range of motion. The company’s Ekso devices are primarily used in a hospital and rehabilitation setting. It has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on reddit

AIM All Share Index